Cytoreduction and Intraperitoneal Chemotherapy for the Management of Non-Gynecological Peritoneal Surface Malignancy

Journal of Experimental and Clinical Cancer Research

Volumn 22, Issue 4 SUPPL., 2003, Pages 109-117

  Yan, T D ^a   Esquivel, J ^a   Carmignani, P ^a   Sugarbaker, P H ^a,b  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b WASHINGTON CANCER INSTITUTE   (United States)

Author keywords

Carcinomatosis; Intraperitoneal chemotherapy; Peritoneal mesothelioma; Peritonectomy; Sarcomatosis

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; FLUOROURACIL; FOLINIC ACID; MITOMYCIN C; PACLITAXEL;

CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER MORTALITY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL EXAMINATION; CLINICAL TRIAL; COLORECTAL PERITONEAL CARCINOMATOSIS; COMORBIDITY; CONFERENCE PAPER; CYTOREDUCTION; EXPERIENCE; HISTOPATHOLOGY; HUMAN; MINIMALLY INVASIVE SURGERY; MORBIDITY; PATIENT SELECTION; PERIOPERATIVE PERIOD; PERITONEAL SURFACE MALIGNANCY; PERITONEUM CANCER; PERITONEUM MESOTHELIOMA; PERITONEUM PSEUDOMYXOMA; PEROPERATIVE CARE; PHYSICIAN ATTITUDE; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; SKILL; STOMACH CARCINOMA; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING;

ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CLINICAL TRIALS; COMBINED MODALITY THERAPY; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; HUMANS; INFUSIONS, INTRALESIONAL; INFUSIONS, PARENTERAL; MALE; PERITONEAL NEOPLASMS; TREATMENT OUTCOME;

EID: 1842426246     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. Savalgi RS. Mechanism of Abdominal Wall Recurrence After Laparoscopic Resection of Colonic Cancers. Semin Laparosc Surg. 1995 Sep;2(3):158-162.
2. Sugarbaker PH, Jablonski KA. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg. 1995 Feb;221(2):124-32.
3. Albelda SM, Buck CA. Integrins and other cell adhesion molecules. FASEB J. 1990 Aug;4(11):2868-80.
4. Gonzalez-Moreno S, Sugarbaker PH. Right colectomy does not confer a survival advantage in patients with mucinous carcinoma of appendix with peritoneal seeding. Br J Surg (in press).
5. Sugarbaker PH, Acherman YI, Gonzalez-Moreno S, et al. Diagnosis and treatment of peritoneal mesothelioma: The Washington Cancer Institute experience. Semin Oncol. 2002 Feb;29(1):51-61.
6. Sridhar KS, Doria R, Raub WA Jr, Thurer RJ, Saldana M. New strategies are needed in diffuse malignant mesothelioma. Cancer. 1992 Dec 15;70(12):2969-79.
7. Acherman YI, Welch LS, Bromley CM, Sugarbaker PH. Clinical presentation of peritoneal mesothelioma. Tumori. 2003 May-Jun;89(3):269-73.
8. Jayne DG, Fook S, Loi C, Seow-Choen F. Peritoneal carcinomatosis from colorectal cancer. Br J Surg. 2002 Dec;89(12):1545-50.
9. Elias D, Blot F, El Otmany A, et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer. 2001 Jul 1;92(1):71-6.
10. Pestieau SR, Sugarbaker PH. Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management. Dis Colon Rectum. 2000 Oct;43(10):1341-6; discussion 1347-8.
11. Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003 Oct 15;21(20):3737-43.
12. Glen O, Kwiatkowski F, Sugarbaker PH, et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer. A multi-institutional study of 506 patients. (J Clin Oncol. Submitted)
13. Moreno SG, Sugarbaker PH. Comprehensive management of resectable gastric cancer: requirement for optimal clearance, containment and perioperative intraperitoneal chemotherapy. Rev Oncologia 2000;2:129-40
14. Yu W, Whang I, Suh I, Averbach A, Chang D, Sugarbaker PH. Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer. Ann Surg. 1998 Sep;228(3):347-54.
15. Yonemura Y, Fujimura T, Nishimura G, et al. Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination. Surgery. 1996 Apr;119(4):437-44.
16. Berthet B, Sugarbaker TA, Chang D, Sugarbaker PH. Quantitative methodologies for selection of patients with recurrent abdominopelvic sarcoma for treatment. Eur J Cancer. 1999 Mar;35(3):413-9.
17. Sugarbaker PH. Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol 1999;43(suppl):S15-S25.
18. Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221(1):29-42.
19. Hayashi T, Nasu Y, Aramaki K, Johsen T, Matsuura H. A case of peritoneal malignant mesothelioma with disappearance of ascites result of intraperitoneal instillation of mitomycin C and oral administration of UFT. Gan To Kagaku Ryoho. 1989 Jul; 16(7):2449-52.
20. Stephens AD, Belliveau JF, Sugarbaker PH. Intraoperative hyperthermic lavage with cisplatin for peritoneal carcinomatosis and sarcomatosis. Cancer Treat Res. 1996;81:15-30.
21. Stephens AD, Alderman R, Chang D, et al. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol. 1999 Dec;6(8):790-6.
22. Sugarbaker PH. New responsibilities in the management of colorectal cancer with peritoneal seeding. Cancer Invest. 2002;20(7&8):1118-22.